舒托必利滴剂治疗精神分裂症及躁狂症急性发作  

Sultopride drops in the treatment of schizophrenia and acute episode of mania

作　　者：甘一方[1] 王祖新[1] 芮清 张艾琳[1] 

机构地区：[1]北京医科大学精神卫生研究所

出　　处：《上海精神医学》1995年第2期79-81,共3页Shanghai Archives of Psychiatry

摘　　要：使用法国德龙药厂Sultopride滴剂治疗17例精神分裂症,8例躁狂症急性发作,显效率为72%;BPRS量表显示滴剂对精神分裂症病人的思维障碍、敌意猜疑,BPRS量表显示对躁狂状态病人的情绪高涨、言语性活动等均有较好的治疗作用;其锥体外系副反应的发生率为64%;剂量不宜超过1000mg/日。Seventeen schizophrenic patients and 8 cases acute episodes of mania were treated with sultopride drops. The response rate was 72%. Sultopride drops had good efficacy on thought disorder and suspiciousness of schizophrenics, and on elation and excitement of manic patients. The prevalence of EPS was 64%.

关 键 词：舒多必利滴剂 精神分裂症 躁狂急性发作 

分 类 号：R749.305[医药卫生—神经病学与精神病学] R971.41[医药卫生—临床医学]